Skip to main content
SpringerLink
Log in

PAF receptor blockade inhibits lung vascular changes in the rat monocrotaline model

  • Published:
Lung Aims and scope Submit manuscript

Abstract

We recently reported that platelet-activating factor (PAF) levels increased in lung tissue after 1 subcutaneous injection of monocrotaline (MCT) (which causes lung injury), and, further, that treatment with PAF antagonists reduced pulmonary hypertension in this chronic lung injury rat model [15]. In the present study, we examined the effect of WEB 2170, a specific PAF antagonist, on MCT-induced pulmonary vascular remodeling. At 3 weeks after MCT injection, pulmonary hypertension in the animals was associated with an increase in the vessel wall thickness of the muscular arteries, reduction in number of peripheral arterioles, and right ventricular hypertrophy. In WEB 2170-treated rats, these changes were significantly less severe when compared with those observed in MCT-treated rats. In MCT-treated rats, there were significant increases in in vitro [3H]thymidine incorporation and accumulation of hydroxyproline in the lung tissue, and these changes were inhibited by WEB 2170 treatment. Our results suggest that PAF or a PAF-dependent sequence of events is involved in MCT-induced lung vascular remodeling.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Benveniste J, Henson PM, Copchrane CG (1972) Leukocyte-dependent histamine release form rabbit platelets: the role of IgE, basophils, and a platelet-activating factor. J Exp Med 136:1356–1377

    Google Scholar 

  2. Collins JF, Durnin LS, Johanson WG (1978) Papain-induced lung injury: alterations in connective tissue metabolism without emphysema. Exp Mol Pathol 29:29–36

    Google Scholar 

  3. Czer GT, Marsh J, Konopka R, Mozar KM (1986) Low-dose PG12 prevents monocrotaline-induced thromboxane production and lung injury. J Appl Physiol 60:464–471

    Google Scholar 

  4. Ghodsi F, Will JA (1981) Changes in pulmonary structure and function induced by monocrotaline intoxication. Am J Physiol 240 (Heart Circ Physiol 9):H149-H155

    Google Scholar 

  5. Heuer HO, Casals-Stenzel J, Muaceric G, Weber KH (1990) Pharmacologic activity of bepafant (WEB 2170), a new and selective hetrazepinoic antagonist of platelet activating factor. J Pharmacol Exp Ther 255:962–968

    Google Scholar 

  6. Hilliker KS, Bell TG, Lorimer D, Roth RA (1984) Effects of thrombocytopenia on monocrotaline pyrrole-induced pulmonary hypertension. Am J Physiol 246 (Heart Circ Physiol 15):H747-H753

    Google Scholar 

  7. Hislop A, Reid L (1976) New findings in pulmonary arteries of rats with hypoxia-induced pulmonary hypertension. Br J Exp Pathol 57:542–554

    Google Scholar 

  8. Kameji K, Otsuka H, Hayashi Y (1980) Increase of collagen synthesis in pulmonary arteries of monocrotaline-treated rats. Experimentia 36:441

    Google Scholar 

  9. Kay JH, Heath D (1969) Crotalaria spectabilis: the pulmonary hypertension plant. Springfield, IL: Charles C Thomas, pp 133–136

    Google Scholar 

  10. McLean EK (1970) The toxic actions of pyrrolizidine (Senecia) alkaloids. Pharmacol Rev 22:429–483

    Google Scholar 

  11. Meyrick B, Gamble W, Reid L (1980). Development of Crotalaria of pulmonary hypertension: hemodynamic and structural study. Am J Physiol 239 (Heart Circ Physiol 8):H692-H702

    Google Scholar 

  12. Meyrick BO, Reid LM (1982) Crotalaria-induced pulmonary hypertension: uptake of 3H-thymidine by the cells of the pulmonary circulation and alveolar walls. Am J Pathol 106:84–94

    Google Scholar 

  13. Mikity VG (1972) Chronic respiratory distress in the premature infant (Wilson-Mikigy Syndrome). In Kendig EL Jr (ed): Pulmonary disorders, Vol 1, Disorders of the respiratory tract in children. WB Saunders, Philadelphia

    Google Scholar 

  14. Ohar JA, Pyle JA, Waller KS, Hyers TM, Webster RO, Lagunoff D (1990) A rabbit model of pulmonary hypertension induced by the synthetic platelet-activating factor, acetylglyceryl ether phosphorylcholine. Am Rev Respir Dis 141:104–110

    Google Scholar 

  15. Ono S, Voelkel NF (1991) PAF antagonists inhibit monocrotaline (MCT)-induced lung injury and pulmonary hypertension. J Appl Physiol 71(6)

  16. Ooshima A, Fuller GC, Cardinale GJ, Spector S, Udenfriend S (1974) Increased collagen synthesis in blood vessels of hypertensive rats and its reversal by antihypertensive agents. Proc Natl Acad Sci 71:3019–3023

    Google Scholar 

  17. Owens GK (1989) Control of hypertrophic versus hyperplastic growth of vascular smooth muscle cells. Am J Physiol 257 (Heart Circ Physiol 26):H1755–1765

    Google Scholar 

  18. Schraufnagel DE, Schmid A (1989) Pulmonary capillary density in rats given monocrotaline: a cast corrosion study. Am Rev Respir Dis 140:1405–1409

    Google Scholar 

  19. Steel RGD, Torrie JY (1960) Principles and procedures of statistics. McGraw-Hill, New York

    Google Scholar 

  20. Stenmark KR, Morganroth ML, Remigi LK, Voelkel NF, Murphy RC, Henson PM, Mathias MM, Reeves JT (1985) Alveolar inflammation and arachidonate metabolism in monocrotaline-induced pulmonary hypertension. Am J Physiol 248 (Heart Circ Physiol 17):H859-H866

    Google Scholar 

  21. Sugita T, Stenmark KR, Wagner WW Jr, Henson PM, Henson JE, Hyers TM, Reeves JT (1983) Abnormal aveolar cells in monocrotaline induced pulmonary hypertension. Exp Lung Res 5:201–215

    Google Scholar 

  22. Sugita T, Hyers TM, Dauber IM, Wagner WW, McMurtry IF, Reeves JT (1983) Lung vessel leak precedes right ventricular hypertrophy in monocrotaline-treated rats. J Appl Physiol 54:371–374

    Google Scholar 

  23. Todorovich-Hunter L, Johnson DJ, Ranger P, Keeley FW, Rabinovitch M (1988) Altered elastin and collagen synthesis associated with progressive pulmonary hypertension induced by monocrotaline. Lab Invest 58:184–195

    Google Scholar 

  24. Turner JH, Lalich JJ (1965) Experimental cor pumonale in the rat. Arch Pathol 84:64–76

    Google Scholar 

  25. Voelkel NF, Wiegers U, Sill V, Trautman J (1977) A kinetic study of lung DNA-synthesis during simulated chronic high altitude hypoxia. Thorax 32:578–581

    Google Scholar 

  26. Voelkel NF (1982) Nonimmunological production of leukotrienes induced by platelet-activating factor. Science 218:286–288

    Google Scholar 

  27. Woessner JF (1961) The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 93:440–447

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiovascular Pulmonary Research Laboratory, University of Colorado Health Sciences Center, 80262, Denver, CO, USA

    S. Ono & N. F. Voelkel

Authors
  1. S. Ono
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. F. Voelkel
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Offprint requests to: N. F. Voelkel

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ono, S., Voelkel, N.F. PAF receptor blockade inhibits lung vascular changes in the rat monocrotaline model. Lung 170, 31–40 (1992). https://doi.org/10.1007/BF00164753

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00164753

Keywords

Search

Navigation